(Q73714861)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10782522%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

House-dust-mite sublingual-swallow immunotherapy (SLIT) in perennial rhinitis: a double-blind, placebo-controlled study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10782522%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

Dermatophagoides pteronyssinus

1 reference

1 reference

S Guez

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10782522%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

C Vatrinet

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10782522%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

R Fadel

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10782522%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

C André

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10782522%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

publication date

1 April 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10782522%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10782522%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

55

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10782522%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

369-375

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10782522%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10782522%20AND%20SRC:MED&resulttype=core&format=json

House dust mite exposure as a cause of asthma

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00413.X

7 January 2021

A combined approach to reduce mite allergen in the bedroom.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00413.X

7 January 2021

Effect of a bed covering system in children with asthma and house dust mite hypersensitivity

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00413.X

7 January 2021

Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by antiallergic drugs

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00413.X

7 January 2021

Specific immunotherapy in asthma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00413.X

7 January 2021

Survey of fatalities from skin testing and immunotherapy 1985-1989.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00413.X

7 January 2021

Position paper: Immunotherapy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00413.X

7 January 2021

A double-blind, placebo-controlled trial by the sublingual route of immunotherapy with a standardized grass pollen extract

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00413.X

7 January 2021

Clinical efficacy of sublingual-swallow immunotherapy: a double-blind, placebo-controlled trial of a standardized five-grass-pollen extract in rhinitis.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00413.X

7 January 2021

Double-blind, placebo-controlled evaluation of sublingual immunotherapy with standardized olive pollen extract in pediatric patients with allergic rhinoconjunctivitis and mild asthma due to olive pollen sensitization.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00413.X

7 January 2021

Randomised controlled trial of local allergoid immunotherapy on allergic inflammation in mite-induced rhinoconjunctivitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00413.X

7 January 2021

Prediction of mite allergen levels by guanine measurements in house-dust samples

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00413.X

7 January 2021

Immunotherapy as an effective tool in allergy treatment

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00413.X

7 January 2021

A placebo-controlled trial of immunotherapy with two extracts of Dermatophagoides pteronyssinus in allergic rhinitis, comparing clinical outcome with changes in antigen-specific IgE, IgG, and IgG subclasses

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00413.X

7 January 2021

Double-blind placebo-controlled study of sublingual immunotherapy with house dust mite extract (D.pt.) in children

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00413.X

7 January 2021

Sublingual-swallow immunotherapy (SLIT) in patients with asthma due to house-dust mites: a double-blind, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00413.X

7 January 2021

Changes in nasal specific IgE to mites after periods of allergen exposure-avoidance: a comparison with serum levels.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2000.00413.X

7 January 2021

10.1034/J.1398-9995.2000.00413.X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10782522%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference